文献速递妇科

良性病变子宫切除术的静脉血栓栓塞并发症:一项全国性队列研究

Venous Thromboembolic Complications to Hysterectomy for Benign Disease: A Nationwide Cohort Study.
PubMed 文献 · J Minim Invasive Gynecol · 2017-12-01

腹腔镜(HR=0.51)和阴式(HR=0.39)子宫切除术的VTE风险显著低于腹式,术后肝素血栓预防使风险显著降低(HR=0.63)。

要点

  • 子宫切除术后30天VTE累积发生率为0.19%。
  • 腹腔镜和阴式子宫切除术的VTE风险低于腹式子宫切除术。
  • 术后肝素血栓预防可显著降低VTE风险,尤其存在危险因素时应考虑。

核心结论

  • 良性病变子宫切除术后30天VTE累积发生率总体较低(0.19%)。
  • 腹腔镜和阴式子宫切除术的VTE风险低于腹式手术。
  • 术后肝素血栓预防显著降低VTE风险,应考虑使用,尤其存在危险因素时。

研究设计与样本

  • 全国性队列研究(加拿大任务组分类II-2),数据来自丹麦国家登记库,纳入1996至2015年因良性病变行子宫切除术的18岁及以上女性。
  • 采用Cox比例风险模型,调整年龄、手术途径和相关合并症。

主要发现

  • 腹式、腹腔镜和阴式子宫切除术组的平均年龄分别为49.9、47.9和54.3岁。
  • 术后30天内VTE粗发生率:腹式0.24%(n=142),腹腔镜0.13%(n=12),阴式0.10%(n=21)。
  • 与腹式手术相比,腹腔镜子宫切除术的VTE风险显著降低(HR=0.51;95%CI 0.28-0.92;p=.03),阴式子宫切除术的VTE风险显著降低(HR=0.39;95%CI 0.24-0.63;p<.001)。
  • 在53566例有术后肝素血栓预防数据的患者中,接受肝素血栓预防者的调整HR为0.63(95%CI 0.42-0.96;p=.03)。

临床怎么用

  • 作者认为,术后肝素血栓预防显著降低VTE风险,应考虑使用,尤其存在危险因素时。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY OBJECTIVE: To estimate the risk of venous thromboembolic complications after abdominal, laparoscopic, and vaginal hysterectomy when performed for benign disorders. DESIGN: A nationwide cohort study (Canadian Task Force classification II-2). SETTING: Data from Danish national registers on all women undergoing hysterectomy for benign conditions from 1996 to 2015. PATIENTS: Women aged 18 years and older who underwent hysterectomy for benign disease were stratified into 3 groups according to the hysterectomy approach: abdominal, laparoscopic, or vaginal. INTERVENTIONS: Hysterectomy. MEASUREMENTS AND MAIN RESULTS: Eighty-nine thousand nine hundred thirty-one women met the inclusion criteria. Venous thromboembolism (VTE) as a diagnosis or cause of death was identified. The risk of postoperative VTE was examined with Cox proportional hazard models adjusting for age, surgical approach, and relevant comorbidities. The mean age was 49.9, 47.9, and 54.3 years for women with abdominal, laparoscopic, and vaginal hysterectomy, respectively. The crude incidences of VTE within 30 days after hysterectomy were 0.24% (n = 142), 0.13% (n = 12), and 0.10% (n = 21). The most important predictors of VTE were the approach to hysterectomy and a history of thromboembolic disease. In the multivariable analysis, the risk of VTE was significantly reduced with laparoscopic hysterectomy (hazard ratio [HR] = 0.51; 95% confidence interval [CI], 0.28-0.92; p = .03) and vaginal hysterectomy (HR = 0.39; 95% CI, 0.24-0.63; p < .001) when compared with the abdominal procedure. Data on postoperative heparin thromboprophylaxis were available in 53 566 patients, and the adjusted HR was 0.63 (95% CI, 0.42-0.96; p = .03) in patients receiving heparin thromboprophylaxis. CONCLUSION: The 30-day cumulative incidence of VTE after hysterectomy for benign conditions was low overall (0.19%). Laparoscopic hysterectomy and vaginal hysterectomy carry a lower risk than the abdominal procedure. Postoperative heparin thromboprophylaxis significantly reduces the risk of VTE and should be considered, especially if risk factors are present.

来源:J Minim Invasive Gynecol,查看原文。版权归原作者所有。

引用

  1. Kahr HS, Thorlacius-Ussing O, Christiansen OB, et al. Venous Thromboembolic Complications to Hysterectomy for Benign Disease: A Nationwide Cohort Study. J Minim Invasive Gynecol. 2017. PMID: 29198736. doi:10.1016/j.jmig.2017.11.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。